Related Experiment Video
Updated: Dec 28, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients
Hossein Moravej1,2, Ruqaiah Altassan3, Jaak Jaeken4
1Neonatal Research Center Shiraz University of Medical Sciences Shiraz Iran.
Background:
Phosphomannomutase 2 deficiency (PMM2-CDG) is the most common congenital disorder of glycosylation (CDG). Hypoglycemia has been reported in various CDG including PMM2-CDG. The frequency and etiology of hypoglycemia in PMM2-CDG are not well studied.
Methods:
We conducted a systematic review of the literature on genetically and/or biochemically confirmed PMM2-CDG patients who developed hypoglycemia. Prospective follow-up information on the patients who received diazoxide therapy was collected and evaluated.
Results:
A total of 165 peer-reviewed articles reporting on 933 PMM2-CDG patients were assessed. Hypoglycemia was specifically mentioned only in 23 of these patients (2.5%). Hyperinsulinism was identified in 10 patients (43% of all hypoglycemic patients). Among these 10 patients, seven were successfully treated with diazoxide. However, most patients remained on therapy longer than a year to stay free of hypoglycemia.
Conclusion:
Hypoglycemia is a rarely reported finding in patients with PMM2-CDG. Diazoxide-responsive hyperinsulinism was found to have a good prognosis on medication in our PMM2-CDG patients with hypoglycemia. No genotype-phenotype correlation was observed with respect to hyperinsulinism. A prospective study should be undertaken to explore the hypothesis that hypoglycemia is underdiagnosed in PMM2-CDG and to evaluate whether hyperinsulinism is always associated with hypoglycemia.
Insights
Hypoglycemia is rare in Phosphomannomutase 2 deficiency (PMM2-CDG), but diazoxide effectively treats associated hyperinsulinism. Further research is needed to understand hypoglycemia
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Phosphomannomutase 2 deficiency (PMM2-CDG) is the most common congenital disorder of glycosylation.
- Hypoglycemia is a known complication in CDGs, but its occurrence and causes in PMM2-CDG are not well understood.
Purpose of the Study:
- To investigate the frequency and etiology of hypoglycemia in PMM2-CDG patients.
- To evaluate the efficacy of diazoxide treatment for hyperinsulinism in this population.
Main Methods:
- Systematic literature review of confirmed PMM2-CDG patients with hypoglycemia.
- Prospective follow-up of patients treated with diazoxide.
Main Results:
- Hypoglycemia was reported in only 2.5% of 933 PMM2-CDG patients.
- Hyperinsulinism was identified in 43% of hypoglycemic patients, with 70% responding well to diazoxide therapy.
- Long-term diazoxide treatment was often necessary to maintain normoglycemia.
Conclusions:
- Hypoglycemia is an infrequent but significant finding in PMM2-CDG.
- Diazoxide-responsive hyperinsulinism has a favorable prognosis with medication.
- Further prospective studies are warranted to explore underdiagnosis of hypoglycemia and its link to hyperinsulinism in PMM2-CDG.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

